Opus Genetics, Inc. (IRD)
5.23
+0.02
(+0.38%)
USD |
NASDAQ |
Apr 24, 16:00
5.215
-0.02
(-0.29%)
After-Hours: 20:00
Opus Genetics Shareholders Equity (Quarterly) : 15.35M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Keros Therapeutics, Inc. | 303.13M |
| Moderna, Inc. | 8.65B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 50.27M |
| Total Liabilities (Quarterly) | 34.92M |
| Debt to Equity Ratio | 0.0736 |
| Current Ratio | 6.432 |
| Net Debt Paydown Yield | -0.16% |